Respimat B (RMT-B)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Respimat B (RMT-B), covering 2014-08-20 to 2014-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B) [Phase 1]